-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Biocept To Explore Strategic Alternatives And Implement Restructuring Plan

Benzinga · 01/06/2023 06:55

Biocept, Inc. (NasdaqCM: BIOC) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Biocept has engaged EF Hutton, division of Benchmark Investments, Inc., as its financial advisor to assist in this process.